NCT03622424View on ClinicalTrials.gov

Effects of Gelesis200 on Appetite Parameters, Food Intake, and Glycemic Control in Overweight or Obese Prediabetic Subjects: A Sub-Study of LIGHT-UP

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 22, 2017

Primary Completion Date

November 19, 2019

Study Completion Date

December 20, 2019

Conditions
Overweight and ObesityPreDiabetesType2 Diabetes
Interventions
DEVICE

Gelesis200

Gelesis200: Three (3)Gelesis200 capsules (2.10 g) three (3) times per day (i.e., breakfast, lunch, and dinner)

DEVICE

Placebo

Placebo: Three (3)placebo capsules three (3) times per day (i.e., breakfast, lunch, and dinner)

DEVICE

Gelesis200 and Placebo

Placebo and Gelesis200: Three (3) placebo capsules at breakfast,and three (3) Gelesis200 capsules (2.10 g)two (2) times per day (i.e., lunch and dinner)

Trial Locations (1)

DK-1958

University of Copenhagan, Frederiksberg

Sponsors

Lead Sponsor

Gelesis, Inc.
All Listed Sponsors
collaborator

University of Copenhagen

OTHER

lead

Gelesis, Inc.

INDUSTRY

NCT03622424 - Effects of Gelesis200 on Appetite Parameters, Food Intake, and Glycemic Control in Overweight or Obese Prediabetic Subjects: A Sub-Study of LIGHT-UP | Biotech Hunter | Biotech Hunter